© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
CE: Emerging Strategies in the Treatment and Management of Idiopathic Pulmonary Fibrosis
Pharmacy Times, April 2020, Volume 88, Issue 4
This activity is supported by an educational grant from Genentech.
EDUCATIONAL OBJECTIVES
At the completion of this activity, the participant will be able to:
- Explore the pathophysiology and treatment challenges associated with idiopathic pulmonary fibrosis (IPF)
- Examine the safety and efficacy of available therapies for the treatment of IPF
- Identify the role of the specialty pharmacist as patient counselor in the management of IPF
FACULTY
Geoffrey C. Wall, PharmD, BCPS, FCCP
Ellis Professor of Pharmacy Practice, Drake University College of Pharmacy and Health Sciences; Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center, Des Moines, Iowa
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: April 13, 2020
EXPIRATION DATE: April 13, 2021
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.
Related Content: